As you delve into the world of type 2 diabetes treatments, you may come across a relatively new drug called Semaglutide. This medication has been generating a significant amount of interest among medical professionals and patients alike, due to its potential to not only control blood sugar levels, but also promote weight loss in those affected by obesity.
You may be wondering about the effectiveness of this medication, how it compares to other treatments, and what the potential side effects could mean for your health.
With a review on the place of semaglutide in therapy for adults with type 2 diabetes and a study examining its antiobesity properties, it’s worth taking the time to understand what this drug brings to the table and how it might fit into your diabetes management plan.
As you read on, you’ll find evidence-based information to help you make an informed decision about whether semaglutide is the right choice for you. While it may offer several benefits for some individuals, it’s essential to maintain a critical eye and consider potential drawbacks as well. We invite you to explore the various facets of this intriguing medication.
What Is Semaglutide?
Semaglutide is a medication marketed under the brand names Ozempic and Wegovy for different indications. Ozempic is approved for managing type 2 diabetes, while Wegovy is prescribed to treat obesity. The pharmaceutical company responsible for the development and marketing of semaglutide is Novo Nordisk.
How It Started
Semaglutide was developed as a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by mimicking the GLP-1 hormone in your body, which regulates glucose levels and insulin secretion. The discovery and development of semaglutide were fueled by the need for more effective treatments in managing type 2 diabetes and obesity.
What Is Semaglutide?
Semaglutide has two main therapeutic uses:
- Ozempic: As an effective tool in managing type 2 diabetes, semaglutide has been studied extensively in clinical trials. Its primary function is to help lower blood sugar levels and improve glycemic control in adults with type 2 diabetes by stimulating insulin secretion and suppressing glucagon, a hormone that raises blood sugar.
- Wegovy: Semaglutide is also available under the brand name Wegovy, specifically designed for weight management and obesity treatment. As a GLP-1 receptor agonist, it helps reduce appetite and promotes weight loss by affecting the hunger and satiety signals in your brain. Clinical trials have shown semaglutide to produce more significant weight loss compared to older anti-obesity medications.
To sum up, semaglutide is a versatile medication with promising benefits in treating type 2 diabetes and obesity. As a patient, it’s recommended to consult with your healthcare professional before starting any new treatment or medication.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, used for the management of type 2 diabetes and weight management. It comes in both subcutaneous (injectable) and oral forms. The oral form is known as Rybelsus.
In the subcutaneous form of semaglutide, you’ll find inactive ingredients such as disodium phosphate dihydrate, propylene glycol, phenol, and water for injection. These ingredients are combined with semaglutide to create a stable, injectable solution. The elimination half-life of semaglutide is approximately one week, which allows for once-weekly dosing.
When it comes to Rybelsus, the oral form of semaglutide, you’ll likely encounter similar ingredients as the injectable version. However, the inactive ingredients in Rybelsus have not been specified in the provided sources. As an oral GLP-1 agonist, the main active ingredient in both forms is semaglutide.
Keep in mind that both the injectable and oral versions of semaglutide come with their own benefits and risks. As with any medication, it’s essential to consult with your healthcare provider before starting semaglutide to ensure it’s the best option for your individual needs and health condition.
Remember, maintaining a neutral and clear tone of voice is essential when discussing the ingredients of semaglutide, as it helps provide a concise overview of this GLP-1 receptor agonist with published evidence to support the provided information.
Semaglutide has shown great potential in helping you achieve significant weight loss. In one study, semaglutide 2.4 mg demonstrated efficacy for obesity treatment. Incorporating this medication into your weight loss plan may boost your efforts, but it’s essential to follow your healthcare provider’s recommendations.
Type 2 diabetes management
Semaglutide is an effective medication for treating type 2 diabetes. It works by mimicking a hormone called glucagon-like peptide-1 (GLP-1), helping to increase insulin production and lower blood sugar levels. In combination with a healthy diet and exercise, this medication can assist with better glycemic control.
Another health benefit of semaglutide is its ability to improve your cholesterol levels. By lowering low-density lipoprotein (LDL) cholesterol, known as the “bad” cholesterol, semaglutide contributes to maintaining a healthier lipid profile, reducing your risk of heart disease.
Blood sugar levels
Semaglutide’s primary function in type 2 diabetes treatment is to regulate blood sugar levels. The medication’s mechanism of action involves stimulating the release of insulin, thus helping to maintain consistent blood sugar levels throughout the day, reinforcing your diabetes management.
High blood pressure
While the primary focus of semaglutide is on diabetes and weight loss, it may also have a positive effect on high blood pressure. Some studies suggest that GLP-1 analogs, like semaglutide, contribute to reducing blood pressure.
Remember, semaglutide may offer several health benefits, but adherence to your prescribed treatment plan and collaboration with your healthcare provider is crucial for achieving your health goals.
Pros and Cons
When considering semaglutide as a treatment option, it’s important for you to weigh the pros and cons of this medication. This section will help you better understand some of the potential advantages and disadvantages of semaglutide.
Pros of semaglutide
- Effective blood sugar control
- Promotes weight loss
- Potential cardiovascular benefits
- Convenient once-weekly dosing
Cons of semaglutide
- Gastrointestinal side effects (nausea, vomiting, diarrhea)
- Possible injection site reactions
- Increased risk of hypoglycemia when combined with certain medications
- Costly, especially without insurance coverage
- Limited long-term data on safety and efficacy
It’s essential to work closely with your healthcare provider. They can help you determine whether this medication is a suitable and safe option for you, while also making sure you maintain a proper diet and exercise routine to maximize its potential benefits.
Always remember to keep your healthcare provider informed about your experiences and concerns with semaglutide to ensure you receive the best possible care.
How to Use?
Before using semaglutide, it’s essential to familiarize yourself with the proper method of administration. Semaglutide is typically given as an injection or shot, and here we will provide you with a brief overview of the process for both methods.
Semaglutide injections are usually administered once per week, and your healthcare provider will help you determine the best dosing schedule for your needs. To administer the injection, follow these steps:
- Prepare your supplies. You’ll need an alcohol swab, disposable syringe, and the semaglutide vial. Make sure all items are clean and unopened before use.
- Wash your hands. Thoroughly wash your hands with soap and water before handling any medication.
- Choose an injection site. The best sites for semaglutide injections are the abdomen or thigh area. Avoid any areas with visible veins, scarring, or irritated skin.
- Clean the site. After selecting the injection site, clean it with an alcohol swab and allow it to air dry.
- Draw up the medication. Carefully remove the vial cap, insert your syringe, and draw up the appropriate dose of semaglutide.
- Give the injection. Pinch a fold of skin at the cleaned injection site, and hold the syringe at a 90-degree angle. Gently insert the needle and slowly depress the plunger to inject the medication. Dispose of the used syringe properly.
Keep track of your injection sites so that you can rotate them each week, which will help reduce the risk of irritation or discomfort.
Oral semaglutide shots are a newer method of administration that has been found to be acceptable for use. Your healthcare provider can guide you on the correct dosing and method for using oral semaglutide shots. Though the exact method and dose may vary, you would typically need to follow these general steps:
- Take the medication at the same time every day, preferably in the morning, with or without food, as directed by your healthcare provider.
- Make sure your hands are clean and dry before handling the medication.
- Open the blister pack by peeling back the foil. Be careful not to push the tablet through the foil.
- Remove one tablet from the blister pack by gently pushing it through the foil or using clean, dry hands.
- Place the tablet on your tongue and allow it to dissolve. Do not chew, crush, or swallow the tablet whole.
- Once the tablet has dissolved, drink a glass of water to ensure that you have swallowed the entire dose.
- If you forget to take a dose, take it as soon as you remember, unless it is close to the time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule.
- Continue taking oral semaglutide as prescribed by your healthcare provider, even if you start feeling better. It is important to maintain consistent medication adherence for optimal effectiveness.
Remember to discuss any concerns or questions with your healthcare provider to ensure that you are confident in administering semaglutide properly using either method. Regularly monitoring your glucose levels and maintaining consistent communication with your healthcare team will help to manage your diabetes effectively.
In your research on semaglutide, you’ll come across a variety of studies that showcase its efficacy and safety.
One study highlights the effectiveness of semaglutide, a glucagon-like peptide-1 receptor agonist, in managing type 2 diabetes. Semaglutide has shown superior results in reducing glycated hemoglobin levels and promoting weight loss compared to placebo and other medications.
It has also demonstrated cardiovascular safety and significant reductions in major cardiovascular events. The study concludes that semaglutide addresses unmet needs in type 2 diabetes treatment and discusses its potential use in clinical practice.
Furthermore, there is another key study that discusses the weight loss efficacy of semaglutide. The study states that once-weekly subcutaneous semaglutide has been approved for treating type 2 diabetes and has shown superior weight loss efficacy compared to other similar medications.
Additionally, a phase II trial demonstrated that once-daily subcutaneous semaglutide resulted in significant weight loss in patients with obesity, indicating its potential as an antiobesity drug.
Since safety is always a priority, you should look at the Safety of Semaglutide study. It details the potential safety risks associated with the drug class and provides valuable information on how to mitigate them.
Remember that semaglutide has been FDA-approved for weight management, making it a notable option for those in need of such therapy. By maintaining a neutral and clear tone, you’ll be able to convey the essential information effectively.
When considering the use of semaglutide, it is essential to be aware of the potential side effects. The most common side effect reported with semaglutide is gastrointestinal, primarily in the form of nausea. While it can be unpleasant, nausea usually decreases over time as your body adjusts.
Aside from nausea, you may also experience other gastrointestinal issues such as diarrhea, constipation, and vomiting. Fortunately, these side effects are generally mild to moderate, and often decrease or resolve with continued treatment. It helps to take necessary precautions like staying hydrated and consuming smaller, more frequent meals to manage these undesirable effects.
However, there are potentially more severe side effects of semaglutide. There have been reports of an increased risk of thyroid tumors with the use of this medication, although the evidence is not clear and more research is needed in this area.
The risk associated with semaglutide may be higher than with other drugs in its class, including liraglutide. Make sure to discuss this potential risk with your healthcare provider before starting treatment.
Another severe side effect to be aware of is pancreatitis. Cases of acute pancreatitis have been reported with semaglutide use, and although uncommon, it is essential to be vigilant for symptoms. If you experience severe abdominal pain, vomiting, or rapid heartbeat, seek medical attention immediately, as pancreatitis can be life-threatening.
Lastly, some people taking semaglutide may experience cramping, often accompanied by gastrointestinal issues. To alleviate cramping symptoms, try altering your diet, avoiding trigger foods, and staying well-hydrated. If cramping persists or worsens, consult your healthcare provider for further evaluation and potential adjustments to your treatment plan.
Despite these potential side effects, semaglutide has proven to be an effective medication for treating obesity and type 2 diabetes. Remember to work closely with your healthcare provider to create a tailored treatment plan addressing your specific needs and concerns.
As you explore the world of semaglutide, it’s crucial to consider the experiences and opinions of those who have used or are currently using this medication. In this section, we will delve into customer reviews, providing you with a better understanding of semaglutide from the perspective of real users.
In many reviews, users highlight the positive impact of semaglutide on their blood sugar levels and weight loss. They often report significant improvements in glucose control, and consistent weight loss throughout their treatment. This aligns with the clinical data on oral semaglutide, which is praised for its efficacy in managing type 2 diabetes and inducing weight reduction.
On the other hand, you may come across reviews discussing potential side effects. Some users mention experiencing mild to moderate gastrointestinal issues such as nausea, bloating, and diarrhea, especially during the initial weeks of treatment. Although these side effects can be unpleasant, they tend to subside over time as the body adjusts to the medication.
Another point you might notice is the convenience and ease of use expressed by some customers. The availability of semaglutide in an oral form has been game-changing for many, as it eliminates the need for injections. This increases the chances of long-term adherence to treatment and overall patient satisfaction.
When it comes to the cost aspect, some users find semaglutide to be expensive compared to other available diabetes treatments. However, it’s worth mentioning that the benefits of this medication, particularly in terms of weight loss and improved glycemic control, may outweigh its cost for many individuals.
As you read through various reviews, it’s essential to keep in mind that individual experiences with semaglutide can vary greatly, and what works for one person may not necessarily work for another. It’s always advisable to consult with your healthcare provider to determine the best course of action for your specific needs and circumstances.
What Do Experts Say
Endocrinologists, obesity medicine specialists, and physicians have been closely observing the impact of semaglutide on patients with type 2 diabetes and obesity. They have seen significant results indicating its effectiveness in treating these health conditions.
As you consult with an endocrinologist, they will likely talk about the safety and efficacy of injectable semaglutide, which has been widely studied. They may also mention that semaglutide has shown reductions in cardiovascular death and major adverse events, albeit at a slower pace in comparison to other medications.
When you speak with a physician, they will likely discuss potential side effects associated with semaglutide, as gastrointestinal disorders are a common concern among patients. They may reference the Eudravigilance Database, which can help determine the severity and frequency of gastrointestinal side effects.
Keep in mind that ongoing post-marketing studies and safety considerations for semaglutide will remain a priority for healthcare professionals involved in its prescription.
Who Is It Good For?
Semaglutide is particularly beneficial for those struggling with type 2 diabetes and seeking to achieve better glycemic control. If you have a high body mass index (BMI) and are in need of losing weight, this medication could be a suitable option for you.
Since semaglutide is associated with possible gastrointestinal disorders in certain subgroups, it’s essential to be aware of potential adverse effects you might experience when starting treatment.
You might notice a temporary loss of appetite while using semaglutide. This can actually be advantageous in managing your BMI and promoting weight loss. By helping balance your blood sugar levels, semaglutide can improve overall health.
To ensure the best, individualized treatment, make sure to consult with your healthcare provider before starting semaglutide. They can provide personalized recommendations based on your medical history and specific needs.
In terms of patient satisfaction, many people report positive experiences with oral semaglutide3. This new formulation is a convenient option for those who prefer an oral medication over injections, making it even more accessible to the type 2 diabetes population.
Who Should Avoid It?
If you’re considering using semaglutide to control your diabetes, there are certain situations where you should avoid it. For starters, if you’re pregnant or planning to become pregnant, you should avoid taking semaglutide. There are limited studies on the effects of semaglutide in pregnant women, and it may pose risks to both the mother and the developing fetus.
Individuals with severe gastrointestinal issues might also want to think twice before using semaglutide. In clinical trials, semaglutide has been associated with gastrointestinal adverse effects such as nausea, vomiting, diarrhea, and constipation. If you already suffer from severe gastrointestinal problems or have a medical history that includes these issues, semaglutide may not be the best option for you.
As with any medication, allergies can play a crucial role in determining whether you can safely take semaglutide. If you’re allergic to semaglutide, or any of its components, it’s important to avoid using the medication. Consult your healthcare provider to discuss alternative treatments for controlling your diabetes.
It’s essential to keep your doctor informed about any other medications you’re currently taking. This is because semaglutide may interact with other medications, potentially leading to unwanted side effects or reducing the effectiveness of your prescribed treatment.
Your healthcare provider will be able to determine if semaglutide is safe for you based on your medical history and current medications.
Lastly, if you’re under the age of 18, it’s important to know that semaglutide has not been approved for use in children or adolescents in the United States. Before considering semaglutide as a treatment option, consult with your healthcare provider about diabetes medications suitable for this age group.
There are several alternatives to semaglutide that are used for the treatment of type 2 diabetes. Some common alternatives include:
- Other GLP-1 receptor agonists. Medications such as liraglutide, exenatide, dulaglutide, and lixisenatide are all GLP-1 receptor agonists that work similarly to semaglutide in reducing blood sugar levels and promoting weight loss.
- DPP-4 inhibitors. Dipeptidyl peptidase-4 (DPP-4) inhibitors, such as sitagliptin, saxagliptin, and linagliptin, are oral medications that increase insulin secretion and decrease glucagon production, helping to control blood sugar levels.
- Insulin. Insulin therapy is commonly used in the management of type 2 diabetes when other medications are not sufficient. Different types of insulin are available, including long-acting, intermediate-acting, and rapid-acting insulin.
- SGLT-2 inhibitors. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors, such as canagliflozin, dapagliflozin, and empagliflozin, work by increasing glucose excretion in the urine, thereby lowering blood sugar levels.
- Metformin. Metformin is a commonly prescribed oral medication that reduces glucose production by the liver and improves insulin sensitivity.
The choice of alternative medication depends on various factors, including individual patient characteristics, preferences, and specific treatment goals. It is important to consult with a healthcare professional to determine the most suitable alternative to semaglutide for individual circumstances.
Cost and Where to Buy
You will need a prescription from your healthcare provider to obtain semaglutide, which is available in two forms: oral and injectable. Both forms have shown comparable hyperglycemia-lowering benefits.
The price of semaglutide depends on various factors, including your location, insurance coverage, and the specific brand you are prescribed. It is worth noting that some nonsurgical weight-loss interventions, such as naltrexone-bupropion, liraglutide, and semaglutide, may not be cost-effective given the general $100,000 threshold.
Therefore, make sure to discuss the pricing and insurance coverage with your care provider to ensure it is affordable for you.
To purchase semaglutide, you can visit your local pharmacy or opt for an authorized online pharmacy. Always ensure that the pharmacy you choose is reputable and follows proper regulations to avoid counterfeit or expired medications. This will guarantee the best quality and effectiveness of the treatment.
By following these steps, you can access semaglutide as an effective treatment for type 2 diabetes mellitus while staying informed about its cost and acquiring it safely.
In your exploration of semaglutide, it is clear that this medication holds promise for those living with type 2 diabetes. As a once-weekly subcutaneous injection, studies have shown semaglutide to be efficacious in lowering HbA1c levels. This can lead to better blood glucose management for individuals, thus helping to minimize the complications associated with this condition.
Moreover, oral semaglutide has been found to effectively and safely lower blood glucose, body weight, and systolic blood pressure. However, it is essential to note that oral semaglutide has been linked to an increased incidence of gastrointestinal side effects.
From a safety perspective, semaglutide generally causes mostly mild side effects and is well-tolerated by the majority of patients. This is an essential factor to consider when evaluating the pros and cons of different medications.
When examining the use of semaglutide for obesity, current literature suggests that both semaglutide and liraglutide play a role in obesity treatment. Deciding which agent to use may depend on factors beyond just their efficacy, such as the patient’s individual needs, medical history, and preferences.
Furthermore, it is crucial to remain aware of the potential side effects and carefully weigh the advantages and drawbacks before incorporating semaglutide into your treatment plan.
How is oral semaglutide different from injectable semaglutide?
Oral semaglutide is co-formulated with sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC) to enhance its absorption in the gastrointestinal tract. This allows the medication to be taken in oral form, providing an alternative for patients who prefer not to use injections. The efficacy and safety profiles of oral semaglutide are similar to those of the injectable version.
What are some key findings from clinical trials on oral semaglutide?
Clinical trials have demonstrated that oral semaglutide effectively reduces blood sugar levels and promotes a significant weight loss in patients with type 2 diabetes. It has also been found to be generally safe, with the most common side effects being gastrointestinal issues, such as nausea and diarrhea.
How does oral semaglutide compare to other GLP-1 receptor agonists?
A systematic review and network meta-analysis comparing oral semaglutide to other GLP-1 receptor agonists found that the 14 mg once-daily dose of oral semaglutide was generally more effective in improving glycemic control and promoting weight loss than other GLP-1 agonists.
What should I consider before starting oral semaglutide treatment?
It’s essential to discuss with your healthcare provider whether oral semaglutide is suitable for you, considering factors like your medical history, current health status, and other medications you may be taking. Your healthcare provider will help you determine the appropriate starting dose and guide you on how to adjust it based on your individual needs and treatment goals.
Make sure to inform your healthcare provider about any pre-existing medical conditions or allergies you may have before starting oral semaglutide.
- Andersen, Andreas, et al. “A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes.” Drugs, vol. 81, no. 9, 8 May 2021, pp. 1003–1030, https://doi.org/10.1007/s40265-021-01499-w.
- Brunton, Stephen A., et al. “Integrating Oral Semaglutide into Clinical Practice in Primary Care: For Whom, When, and How?” Postgraduate Medicine, vol. 132, no. sup2, 8 Sept. 2020, pp. 48–60, https://doi.org/10.1080/00325481.2020.1798162.
- Cabral Lopes, António, et al. “Gastrointestinal Disorders Potentially Associated with Semaglutide: An Analysis from the Eudravigilance Database.” Expert Opinion on Drug Safety, 2 Feb. 2023, pp. 1–7, https://doi.org/10.1080/14740338.2023.2172159.
- Christou, Georgios A., et al. “Semaglutide as a Promising Antiobesity Drug.” Obesity Reviews, vol. 20, no. 6, 15 Feb. 2019, pp. 805–815, https://doi.org/10.1111/obr.12839.
- Di Folco, Ugo, et al. “Effects of Semaglutide on Cardiovascular Risk Factors and Eating Behaviors in Type 2 Diabetes.” Acta Diabetologica, vol. 59, no. 10, 2022, pp. 1287–1294, www.ncbi.nlm.nih.gov/pmc/articles/PMC9288662/, https://doi.org/10.1007/s00592-022-01936-6.
- FDA. “FDA Approves New Drug Treatment for Chronic Weight Management, First since 2014.” FDA, 4 June 2021, www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014.
- Goldenberg, Ronald M., and Oren Steen. “Semaglutide: Review and Place in Therapy for Adults with Type 2 Diabetes.” Canadian Journal of Diabetes, vol. 43, no. 2, Mar. 2019, pp. 136–145, https://doi.org/10.1016/j.jcjd.2018.05.008.
- Hall, Sylvie, et al. “Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-like Peptide (GLP)-1 Receptor Agonist.” Clinical Pharmacokinetics, vol. 57, no. 12, 19 June 2018, pp. 1529–1538, https://doi.org/10.1007/s40262-018-0668-z.
- Kennedy, Cormac, et al. “The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis.” Journal of Clinical Medicine, vol. 12, no. 3, 1 Jan. 2023, p. 772, www.mdpi.com/2077-0383/12/3/772, https://doi.org/10.3390/jcm12030772. Accessed 6 June 2023.
- Mahapatra, Manoj Kumar, et al. “Semaglutide, a Glucagon like Peptide-1 Receptor Agonist with Cardiovascular Benefits for Management of Type 2 Diabetes.” Reviews in Endocrine and Metabolic Disorders, vol. 23, no. 3, 7 Jan. 2022, https://doi.org/10.1007/s11154-021-09699-1.
- Rasmussen, Mads Frederik. “The Development of Oral Semaglutide, an Oral GLP-1 Analog, for the Treatment of Type 2 Diabetes.” Diabetology International, vol. 11, no. 2, 4 Jan. 2020, pp. 76–86, https://doi.org/10.1007/s13340-019-00423-8. Accessed 6 June 2023.
- Ryan, Donna H. “Semaglutide for Obesity: Four STEPs Forward, but More to Come.” The Lancet Diabetes & Endocrinology, vol. 9, no. 5, May 2021, pp. 252–254, https://doi.org/10.1016/s2213-8587(21)00081-4. Accessed 6 June 2023.
- Singh, Awadhesh Kumar, et al. “Oral Semaglutide in Type 2 Diabetes Mellitus: Comprehensive Review, Critical Appraisal and Clinical Consideration of Its Use in India.” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 16, no. 3, Mar. 2022, p. 102436, https://doi.org/10.1016/j.dsx.2022.102436. Accessed 6 June 2023.
- Smits, Mark M., and Daniël H. Van Raalte. “Safety of Semaglutide.” Frontiers in Endocrinology, vol. 12, 7 July 2021, https://doi.org/10.3389/fendo.2021.645563.
- Wilding, John P. H., et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” The New England Journal of Medicine, vol. 384, no. 11, 10 Feb. 2021, pubmed.ncbi.nlm.nih.gov/33567185/, https://doi.org/10.1056/NEJMoa2032183.
- Williams, David R, and Marc Evans. Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies. Vol. 11, no. 10, 3 Sept. 2020, pp. 2221–2235, https://doi.org/10.1007/s13300-020-00917-8. Accessed 6 June 2023.
Next, check out some recent reviews you might find useful: